Erin Wright
Stock Analyst at Morgan Stanley
(4.56)
# 205
Out of 4,870 analysts
220
Total ratings
65.45%
Success rate
14.07%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Overweight | $166 → $181 | $164.25 | +10.20% | 11 | Jun 13, 2025 | |
| MCK McKesson | Maintains: Overweight | $745 → $770 | $724.38 | +6.30% | 7 | Jun 11, 2025 | |
| MOH Molina Healthcare | Initiates: Overweight | $364 | $291.48 | +24.88% | 1 | Jun 9, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $20 → $25 | $22.63 | +10.47% | 3 | May 9, 2025 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $20 → $21 | $24.11 | -12.90% | 22 | May 8, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $548 → $558 | $524.28 | +6.43% | 13 | May 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $379 → $390 | $315.38 | +23.66% | 5 | May 5, 2025 | |
| PETS PetMed Express | Maintains: Underweight | $3.5 → $3.2 | $3.25 | -1.54% | 12 | Apr 17, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $19 | $18.82 | +0.96% | 8 | Mar 6, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $14 → $13 | $13.38 | -2.80% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $238 | $157.53 | +51.08% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $301 → $285 | $237.16 | +20.17% | 3 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $272 | $182.30 | +49.20% | 21 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $15.36 | +49.74% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $179.91 | -4.40% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $643 → $551 | $372.03 | +48.11% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.32 | -38.16% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $71.59 | -9.21% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $66.60 | +50.15% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $300.96 | +95.04% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $260.71 | +15.07% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $13.36 | +214.37% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $195.08 | +47.64% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $147.55 | +138.56% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $2.11 | +1,985.31% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $312.35 | -42.05% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $80.31 | -78.83% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $43.29 | +179.51% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $397.90 | +45.77% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $10.49 | +233.81% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $148.36 | +38.18% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $19.29 | -42.98% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $155.25 | +1.13% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $21.83 | +74.07% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $7.27 | +133.84% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $471.64 | -34.70% | 1 | Oct 25, 2017 |
Cardinal Health
Jun 13, 2025
Maintains: Overweight
Price Target: $166 → $181
Current: $164.25
Upside: +10.20%
McKesson
Jun 11, 2025
Maintains: Overweight
Price Target: $745 → $770
Current: $724.38
Upside: +6.30%
Molina Healthcare
Jun 9, 2025
Initiates: Overweight
Price Target: $364
Current: $291.48
Upside: +24.88%
BrightSpring Health Services
May 9, 2025
Maintains: Overweight
Price Target: $20 → $25
Current: $22.63
Upside: +10.47%
Phibro Animal Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $24.11
Upside: -12.90%
IDEXX Laboratories
May 5, 2025
Maintains: Overweight
Price Target: $548 → $558
Current: $524.28
Upside: +6.43%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $315.38
Upside: +23.66%
PetMed Express
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.25
Upside: -1.54%
Envista Holdings
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $18.82
Upside: +0.96%
Elanco Animal Health
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $13.38
Upside: -2.80%
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $157.53
Upside: +51.08%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $301 → $285
Current: $237.16
Upside: +20.17%
Feb 6, 2025
Maintains: Overweight
Price Target: $280 → $272
Current: $182.30
Upside: +49.20%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $15.36
Upside: +49.74%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $179.91
Upside: -4.40%
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $372.03
Upside: +48.11%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.32
Upside: -38.16%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $71.59
Upside: -9.21%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $66.60
Upside: +50.15%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $300.96
Upside: +95.04%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $260.71
Upside: +15.07%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $13.36
Upside: +214.37%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $195.08
Upside: +47.64%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $147.55
Upside: +138.56%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $2.11
Upside: +1,985.31%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $312.35
Upside: -42.05%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $80.31
Upside: -78.83%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $43.29
Upside: +179.51%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $397.90
Upside: +45.77%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $10.49
Upside: +233.81%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $148.36
Upside: +38.18%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $19.29
Upside: -42.98%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $155.25
Upside: +1.13%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $21.83
Upside: +74.07%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $7.27
Upside: +133.84%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $471.64
Upside: -34.70%